NM_000059.4(BRCA2):c.4453A>G (p.Ile1485Val) AND Hereditary cancer-predisposing syndrome
- Germline classification:
- Conflicting interpretations of pathogenicity (2 submissions)
- Last evaluated:
- Mar 23, 2023
- Review status:
- Somatic classification
of clinical impact: - None
- Review status:
- Somatic classification
of oncogenicity: - None
- Review status:
- Record status:
- current
- Accession:
- RCV001805343.6
Allele description [Variation Report for NM_000059.4(BRCA2):c.4453A>G (p.Ile1485Val)]
NM_000059.4(BRCA2):c.4453A>G (p.Ile1485Val)
Condition(s)
- Name:
- Hereditary cancer-predisposing syndrome
- Synonyms:
- Neoplastic Syndromes, Hereditary; Tumor predisposition; Cancer predisposition; See all synonyms [MedGen]
- Identifiers:
- MONDO: MONDO:0015356; MeSH: D009386; MedGen: C0027672
-
PREDICTED: Rattus norvegicus interleukin 1 receptor-like 1 (Il1rl1), transcript ...
PREDICTED: Rattus norvegicus interleukin 1 receptor-like 1 (Il1rl1), transcript variant X4, mRNAgi|2678969409|ref|XM_039083070.2|Nucleotide
-
heparanase [Salvia divinorum]
heparanase [Salvia divinorum]gi|2789765168|gb|KAL1541680.1||gnl| BEAFC|t1.AAHA92_25871Protein
-
Mus musculus protein phosphatase 1, regulatory (inhibitor) subunit 1C (Ppp1r1c),...
Mus musculus protein phosphatase 1, regulatory (inhibitor) subunit 1C (Ppp1r1c), mRNAgi|29150267|ref|NM_172420.2|Nucleotide
-
SUMMARY OF EVIDENCE - The Use of the Electromotive Drug Administration System in...
SUMMARY OF EVIDENCE - The Use of the Electromotive Drug Administration System in Patients with Superficial Bladder Cancer: A Review of the Clinical Effectiveness, Safety, and Cost-Effectiveness
-
Ponticola bathybius isolate FTG147 cytochrome b (cytb) gene, partial cds; mitoch...
Ponticola bathybius isolate FTG147 cytochrome b (cytb) gene, partial cds; mitochondrialgi|1914871188|gb|MN813628.1|Nucleotide
Your browsing activity is empty.
Activity recording is turned off.
See more...Assertion and evidence details
Last Updated: Sep 29, 2024